Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Chamomile Therapy for GAD
NCT01072344Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2010
- Primary completion
- Jun 2015
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Chamomile Extract with Placebo (2 arms). Primary endpoint: Time to Relapse in Each Treatment Condition at 26 weeks. Started Feb 2010; status: completed.
02
Drugs
chamomile
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT01072344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072344.